SEC Form 4 · accession 0001615774-16-003990
Vivani Medical, Inc. · VANI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Anthony Moses
Officer — Commercial VP Americas
Period of report
Jan 21, 2016
Accepted (ET)
Jan 25, 2016 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001266806
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 1,754 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2,F1 | $4.10 | Jan 21, 2016 | A | 6,908 | A | Jan 21, 2017 | Jan 21, 2026 | Common Stock | 6,908 | 6,908 | D |
| Non-Qualified Stock Option (right to buy)F1 | $12.73 | holding | — | — | — | May 25, 2016 | May 25, 2025 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1Options will vest over a 4 year term, with 25% vesting on the date exercisable as set forth in this Form 4 and thereafter vesting in 12 equal quarterly installments of 6.25%.
- F2N/A